Smart Money Circle

Forget Ozempic & Wegovy. The Biggest Opportunity In Weight Loss Today. Lose Weight, Not Muscle $VERU Guest: * CEO: Dr. Mitchell Steiner * Title: Founder, Chairman, CEO, and President * Website: www.verupharma.com * Ticker: NASDAQ: Veru * Bio: Mitchell S. Steiner, M.D., F.A.C.S. has served as President and Chief Executive Officer of Veru and as a director of the Company since October 2016. Dr. Steiner was the co-founder of Aspen Park and served as Aspen Park's Chief Executive Officer, President and Vice Chairman of the Board from July 2014 to October 2016. From 2014 to 2016, Dr. Steiner was a consultant and then the President, Urology and member of senior management of OPKO Health, Inc. (NYSE:OPK) and had responsibilities for the launch, marketing, sales and reimbursement of 4Kscore prostate cancer test to urologists and primary care physicians. Dr. Steiner was also the co-founder of GTx, Inc., a men's health and oncology public company, where he served as Chief Executive Officer and Vice Chairman of Board of Directors from 1997 to 2014. Dr. Steiner is a Board Certified Urologist and a Fellow of the American College of Surgeons and has held numerous academic appointments, including Assistant Professor of Urology, Cell Biology, and Pathology at Vanderbilt School of Medicine from 1993 to 1995 and Chairman and Professor of Urology, Director of Urologic Oncology and Research and the Chair of Excellence in Urologic Oncology at the University of Tennessee from 1995 to 2004. Dr. Steiner holds a B.A. in Molecular Biology and Chemistry from Vanderbilt University and an M.D. from the University of Tennessee. He performed his surgical and urologic training at The Johns Hopkins Hospital and postdoctoral research fellow in cell biology at Vanderbilt School of Medicine. --- Support this podcast: https://podcasters.spotify.com/pod/show/smartmoneycircle/support

Dallas Cowboys Owner Jerry Jones Invested In GameSquare. The CEO Explains The Future Of Sports $GAME Guest: Justin Kenna CEO of GameSquare Holdings, Inc., (NASDAQ: GAME) Company: GameSquare Holdings Inc. ($GAME) Website: https://www.gamesquare.com/ CEO Bio: Justin Kenna is the CEO of GameSquare Holdings, Inc., (NASDAQ: GAME) (TSXV: GAME) an international esports and gaming company revolutionizing the way brands and game publishers connect with hard-to-reach Millennial and Gen Z audiences. He drives strategic direction, integrating global brands within gaming communities through GameSquare's media agencies, data and analytics solutions, SaaS platforms, esports organizations, and content studio. A seasoned executive with extensive experience in gaming, digital media, and finance, Kenna was recognized in the Leaders Under 40 Sports Business Awards Class of 2023 and on the 2023 Dallas 500 list of the most powerful and influential CEOs in North Texas. As former CFO of FaZe Clan, he helped grow one of the world's most globally recognized gaming brands, which he then acquired in 2023 at GameSquare. He has also held finance roles at Madison+Vine, Goldman Sachs, Ernst & Young, and Deloitte and belongs to the Institute of Chartered Accountants. Under his leadership, GameSquare has partnered with over 150 global brands, including Lenovo, Mastercard and Kraft-Heinz, and established collaborations with major sports leagues like the NFL. His efforts have fostered inclusivity in gaming through campaigns with blue chip brands. Kenna's strategic leadership has attracted prominent investors and board members, including Dallas Cowboys owner Jerry Jones and the Goff Family. Kenna lives in Dallas with his wife and daughter. Company Bio: Building the future of sports. GameSquare's (NASDAQ: GAME) mission is to revolutionize the way brands and game publishers connect with hard-to-reach Gen Z, Gen Alpha, and Millennial audiences. Our next generation media, entertainment, and technology capabilities drive compelling outcomes for creators and maximize our brand partners' return on investment. Through our purpose-built platform, we provide award winning marketing and creative services, offer leading data and analytics solutions, and amplify awareness through FaZe Clan, one of the most prominent and influential gaming organizations in the world. With one of the largest gaming media networks in North America, as verified by Comscore, we are reshaping the landscape of digital media and immersive entertainment. GameSquare's largest investors are Dallas Cowboys owner Jerry Jones and the Goff family. --- Support this podcast: https://podcasters.spotify.com/pod/show/smartmoneycircle/support

How This CEO Creates & Captures Value Sam Rubin President and CEO LightPath Technologies - $LPTH Ticker: $LPTH Website: https://www.lightpath.com/ Guest: Sam Rubin, President & Chief Executive Officer LightPath Technologies (NASDAQ: LPTH) Bio: In Mr. Rubin’s prior senior executive role at Thorlabs, he was responsible for Thorlabs’ Imaging Systems Division, a standalone organization with its own sales and marketing, as well as global responsibility for all of Thorlabs’ Life Science activities. Among the positions he held at Thorlabs, Mr. Rubin founded and grew Thorlabs’s fast-growing operation in China, and spearheaded Thorlabs’ entry and significant growth in the Life Sciences market. As a member of the senior executive team, Mr. Rubin leads new strategic initiatives for Thorlabs, including new product lines, acquisitions, and growth into new markets. Prior to joining Thorlabs, Mr. Rubin co-founded XLight Photonics, an optical communication startup, which was later sold to a telecommunications private equity firm. Mr. Rubin holds a Bachelor of Science degree in Electronic Engineering from Ben Gurion University, a Master of Business Administration degree from New York University, Stern School of Business, and is a graduate of the Executive Education, Program for Leadership Development at Harvard Business School. --- Support this podcast: https://podcasters.spotify.com/pod/show/smartmoneycircle/support

This CEO is Using LSD To Fight Depression, PMS, and Other Mental Health Conditions – Justin Hanka CEO -Co-Founder Of Mind Bio Therapeutics -CSE-MBIO This CEO is Using LSD To Fight Depression, PMS, and Other Mental Health Conditions – Justin Hanka CEO -Co-Founder Of Mind Bio Therapeutics -CSE-MBIO Justin Hanka | Co-founder | Chief Executive Director MindBio Therapeutics Ltd Ticker: $MBIO – Canada. Frankfurt Börse - FRA: WF6 Website: https://www.mindbiotherapeutics.com/ Bio: Justin works in investment banking and financing of mergers and acquisitions and particularly he specializes in capital markets transactions and working with technology in the life and health sciences sector. He is Non-Executive Director of EonX (CSE:EONX), a financial technology company, Non-Executive Chairman of Blackhawk Growth Corp (CSE:BLR), an investment issuer and Non-Executive Director and Chairman of SPARC AI (CSE:SPAI), an engineering company commercializing covert geospatial location and tracking technology for drones. Justin is Co-Founder and CEO of Hardenbrook Group, a merchant and investment bank and Co-founder and CEO of MindBio Therapeutics (CSE:MBIO), a clinical stage pharma developing psychedelic microdosing formulations to treat depression and is currently dosing in multiple Phase 2B clinical trials. Justin is also Co-founder of Life AI Corp, a life sciences technology company developing AI solutions for longevity and enhancing health and wellness at scale. Justin’s expertise and interests span the pharmaceutical and life sciences sector, fin-techs, technology that utilizes AI and machine learning methods, banking and insurance, health and wellness, biohacking, anti-ageing and ecommerce. --- Support this podcast: https://podcasters.spotify.com/pod/show/smartmoneycircle/support

Guest: Paul Warley CEO and President Ascent Solar Technologies Website: https://ascentsolar.com Ticker Symbol: ASTI Bio: Chief Executive Officer Prior to Ascent, Warley was president of Warley & Company LLC, a strategic advisory firm from 2015 to 2022 – providing executive management services, capital advisory, and M&A to middle-market companies in the service, construction, technology, oil & gas, clean energy, food, retail and green-building sectors. While at Warley & Company from 2018 to 2019, he was engaged as chief executive officer and CFO of 360Imaging, a provider of products and services for implant surgery and digital dentistry. From 2011 to 2015, Warley served clients in the alternative energy industry as a managing director and chief compliance officer with Deloitte Corporate Finance. From 1997 to 2011, Warley was managing director and region manager for GE Capital. From 1984 to 1997, Warley served as senior vice president with Bank of America and Bankers Trust. Company Bio: Backed by 20+ years of R&D, 17 years of manufacturing experience, numerous awards, and a comprehensive IP and patent portfolio, Ascent Solar Technologies, Inc. (ASTI) is a leading provider of innovative, high-performance, flexible thin-film solar panels for use in scenarios where traditional rigid solar panels don’t work. Ascent’s photovoltaic (PV) modules have been deployed on space missions, multiple airborne vehicles, agrivoltaic installations, in industrial and commercial construction, and in consumer goods, revolutionizing the use cases and environments for solar power. Ascent Solar’s Headquarters & Perovskite Manufacturing Center of Excellence are located in Thornton, Colorado. --- Support this podcast: https://podcasters.spotify.com/pod/show/smartmoneycircle/support

This CEO Is Using A.I. & Psychedelics To Improve Mental Health Guest: Kathryn Walker is the Founder CEO of Revitalist Lifestyle and Wellness -CSE CALM- RVLWF Ticker: (CSE: CALM) (OTCQB: RVLWF) (FSE: 4DO) Website: https://revitalistclinic.com/ Bio: About Kathryn Walker Kathryn Walker is the CEO of Revitalist Lifestyle and Wellness (CSE: CALM) (OTCQB: RVLWF) (FSE: 4DO) which serves as a leading mental health and wellness company led by a comprehensive team of specialty providers. Kathryn worked at a Level 1 Trauma Center in Tennessee for 9 years before attending anesthesia school at the University of North Carolina-Charlotte. She practiced anesthesia of all specialties for 8 years before opening the first Revitalist location in Knoxville, TN in 2018. Today Kathryn operates as a leading advocate for psychedelic medicine as she continues to advance her comprehensive skill set recently graduating with her second Master's degree in Psychiatric Nursing as a Psychiatric Mental Health Nurse Practitioner. Recognizing the need for community access, Kathryn founded the national mental health 501c3 nonprofit, Community Change Foundation (CommunityChangeFoundation.org). This nonprofit foundation focuses on providing financial assistance to veterans, frontline workers, and the financially disadvantaged seeking help with psychedelic therapies. Kathryn incorporated the Community Change Foundation in 2019. Recognizing the need for education and training advancements, Kathryn founded the American Association of Psychedelics (AAPsychedelics.org). This education non-profit 501c3 aims to continually bring high quality education and training to all disciplines of providers. Kathryn incorporated the American Association of Psychedelics in 2021. Kathryn is the Academic Detailer for the MetroDrug Coalition, she sits on the board for American Association of Psychedelics, Mental Health Association of East Tennessee, Herzig University, and Women in Psychedelics. About Company About Revitalist Lifestyle and Wellness Ltd. Revitalist (CSE: CALM) (OTCQB: RVLWF) (FSE: 4DO) Revitalist Lifestyle and Wellness Ltd. (CSE: CALM) (OTCQB: RVLWF) (FSE: 4DO) is a mental health and wellness company focused on comprehensive care in the ketamine wellness space offering innovative, evidenced-based services. The Company, through its subsidiary Revitalist, operates physical locations and virtual offices across 35 states. Founded and led by Kathryn Walker, an advanced provider in the psychedelic space, Revitalist is at the forefront of this emerging field. --- Support this podcast: https://podcasters.spotify.com/pod/show/smartmoneycircle/support

Guest: Dr. Lynn Kirkpatrick Chief Executive Officer, Ensysce Biosciences Inc. Ticker: $ENSC (NASDAQ) Website: https://ensysce.com/ Bio: Dr. Lynn Kirkpatrick Chief Executive Officer, Ensysce Biosciences Inc. Dr. Kirkpatrick has focused her entire career on drug discovery and development. Former Professor of Chemistry and Biochemistry in Canada, she has been active in both the novel drug discovery as well as clinical development of drug candidates throughout her career. She co-founded three start-up companies and successfully brought three novel cancer drug candidates and two other drug candidates in pain and infectious diseases from bench into human clinical trials. Following the acquisition of the first company she co-founded, ProlX Pharmaceuticals, she became President and CEO of Ensysce Biosciences Inc. and took the company public in 2021. Now Dr. Kirkpatrick is guiding the clinical development of Ensysce’s highly novel pain products, which use compelling chemical approaches to reduce abuse and overdose potential. Dr. Kirkpatrick received her PhD in Medicinal Chemistry from the University of Saskatchewan and completed a post-doctoral fellowship in Pharmacology at Yale University School of Medicine before returning to Canada where she spent 16 years in academia. She has published extensively in the area of targeted cancer drug discovery and development and holds numerous patents for novel drug candidates. Company Bio: Ensysce Biosciences is developing first-in-class and uniquely innovative solutions in oral drug delivery. Our proprietary TAAP™ and MPAR® technologies improve the care and safety of patients by preventing the possibility of both abuse and overdose of prescription drugs. Our mission is to revolutionize the safety and oral delivery of medicines for areas of high unmet need. --- Support this podcast: https://podcasters.spotify.com/pod/show/smartmoneycircle/support

This Biotech CEO Is Using Neuroplastogenic Small-Molecule Therapeutics To Create Next Generation Mental Health. Dr Joseph Tucker – CEO Enveric $ENVB Guest: Dr. Joseph Tucker – CEO – Enveric Biosciences Website: https://www.enveric.com/ Company Bio: Enveric Biosciences, Inc., a biotechnology company, engages in the development of small-molecule therapeutics for the treatment of anxiety, depression, and addiction disorders. Its lead product candidates are EB-002, an active metabolite of psilocybin, which is in preclinical development stage for the treatment of anxiety disorders; and EB-003 that is in preclinical development stage for the treatment mental health. The company also focuses on the development of cannabinoid conjugate molecules for the treatment of pain and cancer. Enveric Biosciences, Inc. is headquartered in Naples, Florida. Dr. Tucker Bio: Dr. Tucker is a seasoned executive who has built several publicly traded biotechnology companies. Dr. Tucker was a founder and Chief Executive Officer of Stem Cell Therapeutics, which he took public on the TSX (TSX: SSS). Trillium Therapeutics (NASDAQ: TRIL, TSX: TRIL) acquired Stem Cell Therapeutics in 2013. Dr. Tucker has also held the position of Co-Founder and Chief Executive Officer of Epimeron Inc., a University of Calgary start-up acquired in the creation of Willow Biosciences Inc. (TSX: WLLW). At Willow, Dr. Tucker served as Executive Chairman and Chief Operating Officer. Prior to founding companies, Dr. Tucker was a healthcare analyst with two investment banks and has also worked in technology commercialization for a university technology transfer office. Dr. Tucker received his Ph.D. in Biochemistry and Molecular Biology from the University of Calgary. --- Support this podcast: https://podcasters.spotify.com/pod/show/smartmoneycircle/support

This CEO Is Using Alpaca DNA To Fight Inflammation & A Lot More! CEO Scinai… Nasdaq $SCNI Guest: Mr. Amir Reichman Title & Company: CEO Scinai Immunotherapeutics Ticker: SCNI Website : https://www.scinai.com/ Bio: Mr. Amir Reichman was appointed as Scinai’s CEO in 2021. Born and educated in Israel, Mr. Reichman most recently served as Head of Global Vaccines Engineering Core Technologies and Asset Management at GSK Vaccines headquarters in Belgium. Prior to his role in global vaccines engineering, he served as Senior Director Global GSK Vaccines Supply Chain. Mr. Reichman joined GSK in 2015 after its acquisition of Novartis Vaccines. At Novartis Vaccines, he held various leadership roles of increasing responsibility in its Global Vaccines Supply Chain Management organization located in Holly Springs, NC, USA. In 2003, Mr. Reichman’s academic work at Ben-Gurion University of the Negev contributed to the founding of NeuroDerm Ltd., an Israeli company focused on transdermal drug delivery systems that was acquired by Mitsubishi Tanabe Pharma in 2017 for $1.1B. He was NeuroDerm’s first employee and served as the company’s Chief Engineer and Senior Scientist until his departure in 2009. Mr. Reichman earned an M.Sc. in Biotechnology Engineering from the Ben-Gurion University of the Negev in Israel, and an MBA in Finance and Health Care Management from the Wharton School of the University of Pennsylvania, USA.” --- Support this podcast: https://podcasters.spotify.com/pod/show/smartmoneycircle/support

How This CEO Is Revolutionizing The Smart Eyewear Market… Innovative Eyewear CEO & Founder - $LUCY Guest: Harrison Gross Founder & CEO Innovative Eyewear $LUCY Ticker: LUCY Website: https://lucyd.co/ Bio: CEO & COFOUNDER HARRISON GROSS Harrison Gross is one of the founders of Innovative Eyewear and has served as our Chief Executive Officer and as a director since August 2019, where he guides the company’s product and brand development. Prior to his employment at Innovative Eyewear, from August 2017 to August 2019, Mr. Gross served in various positions, including chief executive officer and media & UX lead, of Lucyd Ltd., our largest stockholder and the licensor of our technology which is also a smart eyewear development company where he developed the company’s brand identity and oversaw general operations and product development. Additionally, from November 2015 to August 2021, Mr. Gross served as the Digital Media Manager of Tekcapital PLC (“Tekcapital”) (LON: TEK), a university intellectual property investment firm that is the parent company of Tekcapital Europe Limited, and Lucyd Ltd, the holding company for Tekcapital’s shares in Innovative Eyewear, where he created, developed and marketed for the company’s licensed properties. Prior to that, from October 2013 to September 2014, Mr. Gross worked as a credit analyst for a Verizon, Inc. contractor, where he managed credit systems and provided support to Verizon agents. Mr. Gross is a graduate of Columbia University with a BA in Writing and received a BA in Jewish Studies from the Jewish Theological Seminary. Mr. Gross is well qualified to serve as a director due to his substantial knowledge of our products, being a named inventor of most of the Company’s patents and his experience in marketing, product and app development. --- Support this podcast: https://podcasters.spotify.com/pod/show/smartmoneycircle/support

Never Stop Learning With IoT Pioneer David  Ly Founder & CEO Iveda – $IVDA Ticker: $IVDA (Nasdaq) Website: https://iveda.com/ Bio: David Ly is the visionary leader and founder of Iveda. David has served as CEO and Chairman of the Board of Directors since the Company’s inception. He also served as President until February 2014. David has over 20 years of experience in wireless data, cellular, IT, and cloud video surveillance. He was only 27 years old when he founded the Company in 2003 and has become a dynamic leader, building a pioneering cloud video hosting and real-time surveillance infrastructure. David’s major accomplishments include raising over $12 million through angel investors, building an enterprise-class cloud video and IoT platforms, taking the company public, and acquiring a security technology company in Taiwan, positioning Iveda for global growth. David is also responsible for securing the Company’s U.S. and international accounts and forging strategic partnerships with large organizations. Prior to founding the company, David had a successful career in sales and applications engineering. He held positions with several major corporations, including Applications Engineer at Metricom, Inc., Corporate Sales at Nextel Communications, Market Manager at Door To Door Storage, and B2B Sales Manager at T-Mobile USA. While at T-Mobile, David earned the President’s Club Top Salesman Award. David’s experience in sales and marketing and his clear vision of video surveillance through cloud computing have been invaluable to the Company’s success. He served in numerous technology, community, and law enforcement Boards of Directors and Advisory Boards. David received his B.S. Degree in Civil Engineering with a Minor in International Business from San Francisco State University in California. --- Support this podcast: https://podcasters.spotify.com/pod/show/smartmoneycircle/support

Long Term Thinking & Diversification With Jonathan Farr, CFA and Private Markets Director at Homrich Berg ($17B in AUM) Guest: Jonathan Farr, CFA and Private Markets Director at Homrich Berg $17B in AUM Website: https://HomrichBerg.com/ Bio: Jonathan Farr, CFA and Private Markets Director at Homrich Berg ($17B in AUM), an independent wealth management firm that provides fiduciary, fee-only investment management and financial planning services. He leads the diligence efforts for private equity and private credit opportunities for high-net-worth clients, families, and not-for-profits. --- Support this podcast: https://podcasters.spotify.com/pod/show/smartmoneycircle/support

This CEO Is Fighting Inflammation – Sea Star Medical -$ICU- CEO, Eric Schlorff, Shares Timeless Advice Guest: Eric Schlorff has served as the Chief Executive Officer of SeaStar Medical Ticker: $ICU Website: https://seastarmedical.com/ Sea Star Medical YouTube: / @seastarmed Bio: Since 2019, Eric Schlorff has served as the Chief Executive Officer of SeaStar Medical, responsible for the management, strategy, and operations of the company. He has extensive experience in financial planning and managing large, complex organizations and as well as deep knowledge of SeaStar Medical’s business operations, including the scientific basis, regulatory requirements and sales and marketing channels. Prior to joining SeaStar Medical in 2016, Mr. Schlorff spent more than 20 years at Dow Chemical Company, serving in served in multiple role, including Global Director of Alternative Investments for the Dow Chemical Pension Plan, Global Finance Leader for Crop Protection & Seeds at Dow AgroSciences, Global Market Intelligence Leader at Dow AgroSciences, Global Financial Manager of Royalties at Dow Agrosciences, Senior Investment Manager of Alternative Investments at Dow Chemical Company, New Business Development of Pharmaceuticals at Dow Chemical Company, Global Financial Analyst within the New Businesses division at Dow Chemical Company, and Global Financial Analyst within Dow AgroSciences at Dow Chemical Company. Mr. Schlorff has a bachelor’s degree in chemistry and biology from Mac Murray College, an M.S. in pharmacology from Southern Illinois University School of Medicine and a master’s in business administration from University of Illinois Urbana-Champaign. --- Support this podcast: https://podcasters.spotify.com/pod/show/smartmoneycircle/support

Learn Timeless Advice From Matt Radgowski, CEO at Halo Investing, which has transacted over $20B since inception. Website: https://haloinvesting.com/ Bio: Matt has extensive knowledge of the wealth management industry with over 27 years of experience specializing in developing and delivering innovative investment solutions. As CEO, Matt’s goal is twofold, to create an effective marketplace for protective investment products and give advisors the tools to manage the products over time. Prior to Halo, Mr. Radgowski served as the Head of Advisor Solutions at Morningstar. --- Support this podcast: https://podcasters.spotify.com/pod/show/smartmoneycircle/support

Timeless Lessons From Someone Who Worked At Goldman Sachs & PIMCO, Then Started His Own ETF Business. Guest: Howard Chan, Founder and CEO of Kurv Investment Management Website: https://www.kurvinvest.com/ Bio: Howard is an experienced leader in the investment management industry with wide-ranging expertise across asset classes and vehicles. He most recently worked with large asset managers to develop strategic business and investment strategies. Previously, he built and scaled a $5.5 billion UCITS ETF business and managed global fixed-income businesses at PIMCO as well as worked at Goldman Sachs Asset Management in asset allocation for institutional and private wealth clients. He has over 20 years of investment and finance experience. Tickers: • KQQQ • TSLP • NFLP • MSFY • GOOP • AAPY • AMZP --- Support this podcast: https://podcasters.spotify.com/pod/show/smartmoneycircle/support

Greg Beischer President and CEO of Alaska Energy Metals Corporation Ticker: AEMC on TSX Website: https://alaskaenergymetals.com/ Bio: Mr. Beischer is a seasoned explorationist with a solid track record of success, now leading the team at Alaska Energy Metals Corporation. As a founder of predecessor company Millrock Resources, he led the team that built a successful “Project Generator” company that attracted in excess of US$50 million in capital from major mining companies, junior explorers, and investors over a 15-year span. Previously with INCO Ltd., Mr. Beischer is highly knowledgeable on the geology of magmatic nickel–copper–platinum deposits. Also, Mr. Beischer had a period of work with the Bristol Bay Native Corporation, where he forged connections across Alaska. He is a geologist and mining engineering technologist, having graduated from Laurentian University (1987), Sudbury, Ontario, and the Haileybury School of Mines (1981), Haileybury, Ontario, Canada. Mr. Beischer is a certified professional geologist (#10505) with the American Institute of Professional Geologists. Mr. Beischer is the past President of the Alaska Miner’s Association, sits on the Board of Alaska’s Resource Development Corporation, and serves on the Alaska Minerals Commission. He lives in Anchorage, Alaska. --- Support this podcast: https://podcasters.spotify.com/pod/show/smartmoneycircle/support

Democratizing Markets Through Innovation - Tzero.com CEO David Goone Shares Timeless Advice Website: Tzero.com Bio: David Goone is the CEO of tZERO, a financial technology company that democratizes access to capital markets by establishing innovative, transparent, and efficient marketplaces. tZERO works with companies and entrepreneurs to provide unique solutions for primary capital raises and secondary trading. Prior to joining tZERO, Goone was the Chief Strategy Officer of Intercontinental Exchange (ICE), from its earliest days, responsible for many of the strategies that brought ICE from a startup to a global enterprise that operates exchanges, data, businesses, and technologies across all major asset classes. ICE, the parent company of the New York Stock Exchange, is also a significant investor in tZERO. While Goone was at ICE, he also served on numerous boards, including the Depository Trust & Clearing Corporation (DTCC), the Options Clearing Corporation (OCC), and the National Futures Association (NFA). He also was a member of the Commodity Futures Trading Commissions, and Local Advisory Committee, as well as Vice Chairman of Brazil City, a clearing house for Brazil's equity and commodities until its merger with B3 exchange. He also served on the boards of all of ICE's derivative exchanges and was on the board and responsible for ICE Benchmark Administration IBA, which Produced LIBOR. Prior to ICE, Goone was a senior executive at the Chicago Mercantile Exchange, where he created and developed many innovative products. --- Support this podcast: https://podcasters.spotify.com/pod/show/smartmoneycircle/support

Stock Symbol: $GDEVWebsite: https://www.gdev.inc/Meet GDEV GDEV has comprehensive expertise in product development and marketing, ability to create popular in-house IPs and to build robust presence on the most accessible platforms, such as mobile and PC (web browsers and social networks). Our games portfolio is diversified across geography, platforms and number of titles.$480M FY2022 revenue400M+ installs worldwide800+ 2023 headcountThanks to our hit games like Hero Wars, Pixel Gun 3D, Island Hoppers and others, GDEV has reached over 400 million installs worldwide, built a team of 900+ inspired professionals working in 4 studios, and become one of the largest independent mobile game companies in Europe.Our strategic goal is the creation of a collaborative network across our portfolio. We promote active cooperation between studios for incremental value-add and expertise sharing which creates a natural attraction point for the next generation of creative talent.Our StudiosSince our IPO on the Nasdaq stock exchange in 2021, we have experienced significant growth. At that time, we had only one studio with a single popular franchise, but we were determined to expand our presence. Today, GDEV has evolved into a dominant force in the gaming industry, with a diverse and thriving portfolio of studios located worldwide.Nowadays, GDEV has ambitious goals to further strengthen our position in the industry. We believe that our track record of delivering exceptional games and our ability to speak the language of founders truly sets us apart in the industry. With a focus on excellence and a commitment to pushing the boundaries of what is possible, we are poised to continue our success and remain at the forefront of the gaming landscape. --- Support this podcast: https://podcasters.spotify.com/pod/show/smartmoneycircle/support

Know Your Edge – Bill Gebhardt Founder of 10Dynamics, A Systematic Fund With Over $110M In AUM Firm 10 Dynamics Limited www.10dynamics.com Current AUM: $110 million   Founder William (Bill) Gebhardt Founder & Executive Director Bio: William (Bill) Gebhardt is the founder of 10Dynamics and developer of TAD – a technology they developed for systematic trading across multiple markets. TAD is the culmination of nearly 30 years of investment experience in a broad range of markets combined with a rigorous academic background and practical quantitative expertise. Mr. Gebhardt’s experience can be divided into two parts. First, as an academic and “quant”, he received a PhD in Finance from Cornell University focused on applying trading strategies grounded in behavioral finance theories to equities and corporate bonds. He held a position as an Assistant Professor of Finance at the University of California at Davis and later worked for Barclays Global Investors where he was responsible for the research and development of trading signals for BGI’s European Long/Short Equity portfolio. The second part of Mr. Gebhardt’s career focused on proprietary trading and overseeing large proprietary trading businesses. Mr. Gebhardt worked in various roles for commodity trading businesses including Deutsche Bank as Managing Director, Head of European Power and Gas Trading and most recently as a Partner for a private equity funded energy trading merchant, Trailstone, where he was responsible for Trailstone’s European business. Mr. Gebhardt founded 10Dynamics in February 2020 and working with a small team of colleagues has fully implemented and automated the TAD system. Mr. Gebhardt has a B.S. in Chemical Engineering, an M.S. in Finance and a PhD in Finance. He has published peer-reviewed academic papers in the Journal of Accounting Research and Journal of Financial Economics. --- Support this podcast: https://podcasters.spotify.com/pod/show/smartmoneycircle/support

Trend Following Legend & Former Turtle Trader Jerry Parker Shares Timeless Advice- Do The Hard Thing Bio: Jerry Parker is the Chairman and Chief Executive Officer of Chesapeake Capital. Chesapeake is a Commodity Trading Advisor in Tampa, Florida. Chesapeake uses a diversified, systematic, trend-following approach. Chesapeake seeks to generate uncorrelated returns across more than 400 global futures and securities instruments. He founded Chesapeake in February 1988. Chesapeake is a subadvisor to the Blueprint Chesapeake Multi-Asset Trend ETF, the Cambria Chesapeake Pure Trend ETF, and the AXS Chesapeake Strategy Mutual Fund. Jerry started his trading career in 1983 in Chicago when Richard Dennis hired him for the Turtle trading program. He received a Bachelor of Science in Accounting from the McIntire School of Commerce at the University of Virginia in 1980. Websites: Chesapeakecapital.com The fund websites are tfpnetf.com https://www.cambriafunds.com/mfut and https://www.axsinvestments.com/eqchx/ --- Support this podcast: https://podcasters.spotify.com/pod/show/smartmoneycircle/support